Study of Lumateperone for Autism-Related Irritability in Teens
Part of Brain & nervous system, Mental health clinical trials.
This study tests a new medication called Lumateperone to see if it can reduce irritability in children and teens with autism. It's a 3-month trial that compares the study drug to a placebo (a pill with no active medicine) to find out if it helps with mood and behavior.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 13 and 17 years old (the study is currently enrolling teens)
- You need a parent or legal guardian who can come to all study visits and help the team take care of you
- You must have a diagnosis of autism spectrum disorder (ASD) and have noticeable irritability
- You should not have another major psychiatric diagnosis, except for ADHD if you are on stable medication
- You cannot have Rett syndrome, Fragile X syndrome, or be at immediate risk of harming yourself
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a combination of two medications (KarXT and KarX-EC) can help reduce irritability in children and teens with autism. It's for those who have significant irritability symptoms that affect daily life.
This study tests an investigational medication called lumateperone to see if it can reduce irritability in children and teens with autism. It is for teenagers aged 13–17 whose irritability is causing significant problems.
This trial tests a combination of two drugs, KarXT and KarX-EC, to see if they can reduce irritability in children and teens with autism spectrum disorder. If your child has significant irritability linked to their autism, this study may offer a new treatment option.
This study tests a new medication called lumateperone for treating depression in children and teens with bipolar disorder. It aims to see if this drug can help improve mood and daily functioning.
This trial looks at the long-term safety of KarXT, a medication for schizophrenia, and KarX-EC for irritability related to autism in teenagers. It is for teens who have already completed the main part of a previous study without serious side effects.
This trial tests a medication called lumateperone for children and teens with schizophrenia, bipolar disorder, or autism spectrum disorder. It aims to see if the medicine is safe and tolerable over time.
Hear when a new Irritability Associated With Autism Spectrum Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.